Huiying Li
Tsinghua University
6 Papers
Huiying Li is an academic researcher from Tsinghua University. The author has contributed to research in topics: Medicine & Mouse model of colorectal and intestinal cancer. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study.
Xujun Liang,Huiying Li,Shao Li +2 more
TL;DR: A holistic analysis method that combines chemical and therapeutic properties with network pharmacology, using a novel approach to evaluate the importance of the targets and ingredients of herbal formulae, and implies new applications of classic herbalformulae.
243
A Network Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Ge-Gen-Qin-Lian Decoction for Treatment of Type 2 Diabetes
Huiying Li,Linhua Zhao,Bo Zhang,Yuyu Jiang,Xu Wang,Yun Guo,Hongxing Liu,Shao Li,Tong Xiaolin +8 more
TL;DR: A network pharmacology strategy used here provided a powerful means for identifying bioactive ingredients and mechanisms of action for TCM herbal formulae, including Ge-Gen-Qin-Lian decoction, including Puerariae Lobatae radix.
Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach
Quan Qi,Rui Li,Rui Li,Huiying Li,Yubing Cao,Ming Bai,Xiao-jing Fan,Shu-yan Wang,Bo Zhang,Shao Li +9 more
TL;DR: By using a TCM network pharmacology method, nuciferine is identified as an anti-tumor agent against human neuroblastoma and mouse colorectal cancer in vitro and in vivo, through inhibiting the PI3K-AKT signaling pathways and IL-1 levels.
Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer
TL;DR: A longitudinal microbial network was constructed for the gut microbiome and showed that the phylotype shifts during this process were complex and highly dynamic, which may provide a deeper understanding of the role of the microbiota and microbe-host interactions in colitis-associated colorectal cancer.
Bruceine A protects against diabetic kidney disease via inhibiting galectin-1.
Huiying Li,Xiao li Zhao,Liyun Zheng,Xiukun Wang,Shuai Lin,Jia-jia Shen,Hangjiang Ren,Yi Bin Li,Qiang Qiu,Zhen Wang +9 more
TL;DR: In this paper , the authors identified Bruceine A as a kidney protective molecule against a model of diabetic kidney disease in db/db mice with potent anti-inflammatory activity both in vitro and in vivo.
15